Relationship between free fatty acids, insulin resistance markers, and oxidized lipoproteins in myocardial infarction and acute left ventricular failure

Diabetes, Metabolic Syndrome and Obesity

Volumn 6, Issue , 2013, Pages 103-111

  Gruzdeva, Olga ^a   Uchasova, Evgenya ^a   Dyleva, Yulia ^a   Belik, Ekaterina ^a   Kashtalap, Vasily ^a   Barbarash, Olga ^a  

^a RESEARCH INSTITUTE FOR COMPLEX ISSUES OF CARDIOVASCULAR DISEASES   (Russian Federation)

Author keywords

Free fatty acids; Insulin resistance; Myocardial infarction

Indexed keywords

APOLIPOPROTEIN B; C PEPTIDE; CHOLESTEROL; CREATINE KINASE; FATTY ACID; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE MARKER; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FAILURE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OXIDATION; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84874375557     PISSN: 11787007     EISSN: None     Source Type: Journal    
DOI: 10.2147/DMSO.S37830     Document Type: Article

References (16)

1. Pirro M, Mauriege P, Tchernof A, et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec cardiovascular study. Atherosclerosis. 2002;160: 377-384.
2. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation. 2002;105: 1727-1733.
3. van der Vusse GJ, van Bilsen M, Glatz JF, Hasselbaink DM, Luiken J. Critical steps in cellular fatty acid uptake and utilization. Mol Cell Biochem. 2002;239:9-15.
4. Lopaschuk GD, Ussher JR, Folmes CDL, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207-258.
5. Kleinfeld AM, Prothro D, Brown DL, Davis RC, Richieri GV, DeMaria A. Increases in serum unbound free fatty acid levels following coronary angioplasty. Am J Cardiol. 1996;78:1350-1354.
6. Opie LH, Knuuti J. The adrenergic-fatty acid load in heart failure. J Am Coll Cardiol. 2009;54:1637-1646.
7. Leclercq IA, Da Silva Morais A, Schroyen B, Van Hul N, Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. J Hepatol. 2007;47:142-156.
8. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73-78.
9. Lee RT, Libby P. The unstable atheroma. J Arterioscler Thromb Vase Biol. 1997;17:1859-1867.
10. Naruko T, Ueda M, Ehara S, et al. Persistent high levels of plasma oxidized low-density lipoprotein after acute myocardial infarction predict stent restenosis. Arterioscler Thromb Vasc Biol. 2006;26:877-883.
11. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-2410.
12. Khot UN, Khot MB, Bajzer CT, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003;290: 898-904.
13. Ansell BJ, Navab M, Hama S, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003;108: 2751-2756.
14. Balent B, Goswami G, Goodloe G, et al. Acute elevation of NEFA causes hyperinsulinemia without effect on insulin secretion rate in healthy human subjects. Ann N Y Acad Sci. 2002;967:535-543.
15. Wu R, Lefvert AK. Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol. 1995;102:174-180.
16. Virella G, Lopes-Virella MF. Lipoprotein autoantibodies: measurement and significance. Clin Diagn Lab Immunol. 2003;10:499-505.